Safety system for preparing cytostatic doses for administration (CSTD) 2027–2032

Summary

The tender concerns a closed-system transfer device (CSTD) for preparing cytostatic and monoclonal antibody doses in a pharmacy and administering them to patients. The system is intended to prevent staff and patients from being exposed to harmful drug splashes, aerosols, vapours and needlestick injuries. Infusion equipment and fluid-transfer cannulas are excluded from the procurement. The tender consists of one lot. The fixed-term contract period is two years, after which the contract continues indefinitely; a new competition is planned within four to five years. The estimated contract start is January 2027, and the tender submission deadline is 23 October 2026.